Milestone Investment Advisors LLC Buys 160 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Milestone Investment Advisors LLC boosted its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 2.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 6,890 shares of the financial services provider’s stock after purchasing an additional 160 shares during the period. Milestone Investment Advisors LLC’s holdings in iShares Biotechnology ETF were worth $911,000 at the end of the most recent quarter.

A number of other hedge funds have also added to or reduced their stakes in IBB. Raymond James Financial Inc. bought a new stake in shares of iShares Biotechnology ETF in the fourth quarter worth $55,010,000. Aprio Wealth Management LLC bought a new stake in shares of iShares Biotechnology ETF during the 4th quarter valued at about $18,476,000. Generali Investments CEE investicni spolecnost a.s. purchased a new stake in shares of iShares Biotechnology ETF during the 4th quarter valued at about $11,370,000. Independent Advisor Alliance bought a new position in shares of iShares Biotechnology ETF in the 4th quarter worth approximately $6,769,000. Finally, Wellington Shields Capital Management LLC boosted its holdings in shares of iShares Biotechnology ETF by 1,753.4% in the fourth quarter. Wellington Shields Capital Management LLC now owns 39,663 shares of the financial services provider’s stock worth $5,244,000 after buying an additional 37,523 shares during the last quarter. 62.45% of the stock is currently owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Trading Up 1.9 %

Shares of IBB stock opened at $126.79 on Thursday. iShares Biotechnology ETF has a 12 month low of $123.21 and a 12 month high of $150.57. The stock has a market cap of $5.99 billion, a P/E ratio of 27.83 and a beta of 0.84. The company has a 50 day simple moving average of $135.64 and a two-hundred day simple moving average of $138.50.

iShares Biotechnology ETF Increases Dividend

The business also recently disclosed a dividend, which was paid on Friday, March 21st. Stockholders of record on Tuesday, March 18th were paid a $0.1212 dividend. This is a positive change from iShares Biotechnology ETF’s previous dividend of $0.06. The ex-dividend date was Tuesday, March 18th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.